Patents by Inventor Don Yang
Don Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230372076Abstract: The present disclosure relates to an implant for pelvic and hip plasty, more particularly, to an implant for pelvic and hip plasty to increase a pelvis and hip volume of a human, the implant for pelvic and hip plasty includes an outer cover which has an interior space, includes an elastic material, and is to be placed in pelvis and hip tissues, a polymer gel filled in the interior space of the outer cover, and a flange portion which protrudes from an edge of the outer cover and is in close contact with and fixed to an iliac crest of a human.Type: ApplicationFiled: October 5, 2021Publication date: November 23, 2023Inventors: Won Don YANG, Yougun WON, Tae Jin LEE
-
Publication number: 20230008057Abstract: A system for representing insurance products as directed graphs and transforms the directed graphs into graph object artifacts for execution. The system includes a compiler, an execution engine and a web-based runtime environment. The compiler transforms source code defining an insurance product as a directed graph into a plurality of nodes, where each node represents one of a computation and an input, and outputs a graph object artifact. The execution engine has an execution model derived from the graph object artifact that is loaded into memory and an application program interface that provides an interface to the web-based runtime environment. The web-based runtime environment provides a layer of abstraction between the execution engine and external services or systems.Type: ApplicationFiled: July 7, 2022Publication date: January 12, 2023Inventors: Keith Alan Hendry, Nicholas Douglas Flanders, Kai-Zhou Don Yang
-
Patent number: 7852449Abstract: A liquid crystal display (LCD) device includes first and second substrates facing each other, a plurality of column spacers on at least one of the first and second substrates, each column spacer including first pattern second patterns, the first and second patterns being connected to each other, the second pattern having a contact surface less than the first pattern, and a liquid crystal layer between the first and second substrates.Type: GrantFiled: June 9, 2009Date of Patent: December 14, 2010Assignee: LG Display Co., Ltd.Inventors: Jeom Jae Kim, Hong Man Moon, Sung Hak Jo, Sang Don Yang
-
Patent number: 7745439Abstract: The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and prevention of disorders modulated by PPARs, i.e., metabolic syndromes such as diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism and hypertension, inflammatory diseases such as osteoporosis, liver cirrhosis and asthma, and cancer.Type: GrantFiled: April 12, 2005Date of Patent: June 29, 2010Assignees: Korea Research Institute of Chemical Technology, Jeil Pharm. Co., Ltd., Korea Research Institute of Bioscience and Biotechnology, CJ Corp.Inventors: Hyae Gyeong Cheon, Sung-Eun Yoo, Sung Soo Kim, Sung-Don Yang, Kwang-Rok Kim, Sang Dal Rhee, Jin Hee Ahn, Seung Kyu Kang, Won Hoon Jung, Sung Dae Park, Nam Gee Kim, Sun Mee Kim, Kil Woong Mo, Jae Mok Lee, Hye Jung Kang, Koun Ho Lee, Jong Hoon Kim, Jeong-Hyung Lee, Seung Jun Kim
-
Patent number: 7741323Abstract: An indene derivative for selectively modulating the activities of peroxisome proliferator activated receptors (PPARs) having the following formula (I): wherein, R1 is C1-6 alkyl, C1-6 alkenyl, or C3-6 cycloalkyl, each of which is unsubstituted or substituted with one or more phenyl groups; R2 is H, CN, CO2Ra, CH2CO2Ra, CONRbRc, or phenyl; R3 is C1-6 alkyl, C3-6 cycloalkyl, naphthyl, phenyl, being each unsubstituted or substituted with one or more substituents selected from the group consisting of halogen, CN, NH2, NO2, ORa, phenyloxy, C1-6 alkyl, and C3-6 cycloalkyl; and R4, R5, R6, and R7 are each independently H, OH, OSO2CH3, O(CH2)mRe, CH2Rf, OCOCH2ORg, OCH2CH2ORg, OCH2CH?CHRg, or pyridine-2-yloxy, or R5 and R6 together form OCH2O.Type: GrantFiled: April 13, 2005Date of Patent: June 22, 2010Assignees: Korea Research Institute of Chemical Technology, Jeil Pharm. Co., Ltd., Korea Research Institute of Bioscience and Biotechnology, CJ Corp.Inventors: Hyae Gyeong Cheon, Sung-Eun Yoo, Sung Soo Kim, Sung-Don Yang, Kwang-Rok Kim, Sang Dal Rhee, Jin Hee Ahn, Seung Kyu Kang, Won Hoon Jung, Sung Dae Park, Nam Gee Kim, Jang Hyuk Lee, Sun Chul Huh, Jae Mok Lee, Seog Beom Song, Soon Ji Kwon, Jong Hoon Kim, Jeong-Hyung Lee, Seung Jun Kim
-
Publication number: 20090262293Abstract: A liquid crystal display (LCD) device includes first and second substrates facing each other, a plurality of column spacers on at least one of the first and second substrates, each column spacer including first pattern second patterns, the first and second patterns being connected to each other, the second pattern having a contact surface less than the first pattern, and a liquid crystal layer between the first and second substrates.Type: ApplicationFiled: June 9, 2009Publication date: October 22, 2009Inventors: Jeom Jae Kim, Hong Man Moon, Sung Hak Jo, Sang Don Yang
-
Patent number: 7576826Abstract: A liquid crystal display (LCD) device includes first and second substrates facing each other, a plurality of column spacers on at least one of the first and second substrates, each column spacer including first pattern second patterns, the first and second patterns being connected to each other, the second pattern having a contact surface less than the first pattern, and a liquid crystal layer between the first and second substrates.Type: GrantFiled: June 7, 2004Date of Patent: August 18, 2009Assignee: LG Display Co., Ltd.Inventors: Jeom Jae Kim, Hong Man Moon, Sung Hak Jo, Sang Don Yang
-
Patent number: 7475394Abstract: A method for analyzing the performance of a program when running in an interpreted environment. An interpreter is a program that translates and executes another program. To analyze a binary in an interpreted environment, a mechanism is used to indicate points in the program at source, intermediate, or binary showing where information about the system is to be tracked/profiled/analyzed. Once these analysis points are determined, triggers are created in a separate file or inserted via program instrumentation into the binary to indicate to the interpreter when the analysis triggers need to be processed. The system being analyzed is then run via an interpreter. When one of these triggers occurs during execution, the interpreter calls analysis code passing it the appropriate information so that it may track statistics, metrics, and information about the program corresponding to the trigger.Type: GrantFiled: December 5, 2003Date of Patent: January 6, 2009Assignee: ARM LimitedInventors: Brad Calder, Todd Austin, Don Yang, Timothy Sherwood
-
Publication number: 20070225288Abstract: The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and prevention of disorders modulated by PPARs, i.e., metabolic syndromes such as diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism and hypertension, inflammatory diseases such as osteoporosis, liver cirrhosis and asthma, and cancer.Type: ApplicationFiled: April 12, 2005Publication date: September 27, 2007Inventors: Hyae Gyeong Cheon, Sung-Eun Yoo, Sung Soo Kim, Sung-Don Yang, Kwang-Rok Kim, Sang Dal Rhee, Jin Hee Ahn, Seung Kyu Kang, Won Hoon Jung, Sung Dae Park, Nam Gee Kim, Sun Mee Kim, Kil Woong Mo, Jae Mok Lee, Hye Jung Kang, Koun Ho Lee, Jong Hoon Kim, Jeong-Hyung Lee, Seung Jun Kim
-
Publication number: 20070185109Abstract: The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and prevention of disorders modulated by PPARs, i.e., metabolic syndromes such as diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism and hypertension, inflammatory diseases such as osteoporosis, liver cirrhosis and asthma, and cancer.Type: ApplicationFiled: April 13, 2005Publication date: August 9, 2007Inventors: Hyae Gyeong Cheon, Sung-Eun Yoo, Sung Soo Kim, Sung-Don Yang, Kwang-Rok Kim, Sang Dal Rhee, Jin Hoe Ahn, Seung Kyu Kang, Won Hoon Jung, Sung Dae Park, Nam Gee Kim, Jang Hyuk Lee, Sun Chul Huh, Jae Mok Lee, Seog Beom Song, Soon Ji Kwon, Jong Hoon Kim, Jeong-Hyung Lee, Seung Jun Kim
-
Publication number: 20050125777Abstract: A method for analyzing the performance of a program when running in an interpreted environment. An interpreter is a program that translates and executes another program. To analyze a binary in an interpreted environment, a mechanism is used to indicate points in the program at source, intermediate, or binary showing where information about the system is to be tracked/profiled/analyzed. Once these analysis points are determined, triggers are created in a separate file or inserted via program instrumentation into the binary to indicate to the interpreter when the analysis triggers need to be processed. The system being analyzed is then run via an interpreter. When one of these triggers occurs during execution, the interpreter calls analysis code passing it the appropriate information so that it may track statistics, metrics, and information about the program corresponding to the trigger.Type: ApplicationFiled: December 5, 2003Publication date: June 9, 2005Inventors: Brad Calder, Todd Austin, Don Yang, Timothy Sherwood